MHC Class I Antigens and Laryngeal Cancer Aggressiveness
Author Information
Author(s): F. Esteban, A. Concha, M. Delgado, M. Perez-Ayala, F. Ruiz-Cabello, F. Garrido
Primary Institution: Hospital 'Virgen de las Nieves', Granada, Spain
Hypothesis
The study aims to evaluate the prognostic significance of MHC class I antigens in patients with laryngeal carcinoma.
Conclusion
The absence of HLA class I antigens in laryngeal tumors is associated with greater local aggressiveness and worse prognosis.
Supporting Evidence
- HLA class I losses were found in a group of tumours showing greater aggressiveness and worse prognosis.
- Most class I negative tumours were classified as advanced stages.
- Class I negative tumours exhibited a short first symptom-diagnosis interval.
Takeaway
This study found that laryngeal tumors without certain proteins (HLA class I antigens) tend to be more aggressive and harder to treat.
Methodology
The study evaluated 60 primary laryngeal tumors and lymph node metastases for MHC class I antigen expression using monoclonal antibodies and statistical analysis.
Limitations
The follow-up period was short, ranging from 12 to 48 months.
Participant Demographics
All participants were male, aged 44 to 75 years, with an average age of 58.68.
Statistical Information
P-Value
0.1771
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website